Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial
Journal of Extracellular Vesicles · 2024-07 · 13 (7)
DOI: 10.1002/jev2.12492 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 25.07.2024. Verfasst von Mohammad Hossein Zamanian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: COVID-19, Extracellular Vesicles, Placenta, Mesenchymal Stem Cells. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The current study aimed to investigate the effects of human placental mesenchymal stromal cell‐derived small extracellular vesicles (hPMSC‐sEVs) as a treatment for COVID‐19. This double‐blind, randomized, controlled clinical trial was conducted on two groups of patients with COVID‐19‐associated acute respiratory distress syndrome. After randomization, the control group received standard treatment and placebo, and the intervention arm received standard treatment plus hPMSC‐sEVs. The number of hospital deaths was considered the primary outcome. After meeting the exclusion and inclusion criteria, 21 and 24 patients were allocated to intervention and control arms, respectively. Besides admission SpO 2 levels, which were significantly lower in the intervention arm ( p = 0.008), all the baseline demo‐biographic and laboratory variables were similar between the groups. It was shown that hPMSC‐sEVs could significantly ( p = 0.015) decrease the mortality ratio in the intervention group (4/21 [19.04%]) compared to the controls (13/24 [54.16%]). The mean time to death in the intervention and control groups was 28.06 and 11.10 days, respectively ( p < 0.001). This study showed that hPMSC‐sEVs are a possible treatment for critically ill patients with COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Medical Biology Research Centre, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Bone Marrow Transplantation Department, School of Medicine, Kermanshah, University of Medical Sciences, Kermanshah, Iran.
- Department of Infectious Disease, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Motazedi Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Translational Type 1 Diabetes, Department of Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
ORCID-Profile: Kamran Mansouri
Zitieren
APA
Zamanian, M. H., Norooznezhad, A. H., Hosseinkhani, Z., Hassaninia, D., Mansouri, F., Vaziri, S., Payandeh, M., Heydarpour, F., Kiani, S., Shirvani, M., Rajati, M., Bakhtiari, M., Esmaili, F., Yarani, R., & Mansouri, K. (2024). Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial. Journal of Extracellular Vesicles, 13(7). https://doi.org/10.1002/jev2.12492
Vancouver
Zamanian MH, Norooznezhad AH, Hosseinkhani Z, Hassaninia D, Mansouri F, Vaziri S, et al. Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial. Journal of Extracellular Vesicles. 2024;13(7). doi:10.1002/jev2.12492
BibTeX
@article{Zamanian2024,
author = {Zamanian, Mohammad Hossein and Norooznezhad, Amir Hossein and Hosseinkhani, Zohreh and Hassaninia, Daryoush and Mansouri, Feizollah and Vaziri, Siavash and Payandeh, Mehrdad and Heydarpour, Fatemeh and Kiani, Sara and Shirvani, Maria and Rajati, Mojgan and Bakhtiari, Mitra and Esmaili, Farzaneh and Yarani, Reza and Mansouri, Kamran},
title = {Human placental mesenchymal stromal cell‐derived small extracellular vesicles as a treatment for severe COVID‐19: A double‐blind randomized controlled clinical trial},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {7},
doi = {10.1002/jev2.12492}
}
EUVIMED